# LYRA (Lyra Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Lyra Therapeutics, Inc. reported $398K in revenue and a net loss of $28.92M for the fiscal year ended December 31, 2025 (down 74.1% year over year), with a -7794.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/LYRA
- Markdown: https://convexityos.com/fundamentals/LYRA.md
- SEC CIK: 0001327273
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001327273&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $398K | -74.1% YoY |
| Operating Income | FY 2025 | -$31.02M | -7794.5% margin |
| Net Income | FY 2025 | -$28.92M | -7266.1% net margin |
| Diluted EPS | FY 2025 | -$18.62 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$28.98M | -7280.2% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $15.89M | Total debt: $30.26M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $398K | $1.53M | $1.56M | $1.36M | $285K | -- | -- |
| Research & Development | $18.41M | $43.77M | $48.03M | $38.80M | $29.69M | $12.52M | $12.03M |
| Total Operating Expenses | $31.42M | $97.88M | $68.68M | $57.67M | $43.90M | $22.21M | $16.52M |
| **Operating Income** | -$31.02M | -$96.35M | -$67.12M | -$56.31M | -$43.62M | -$22.21M | -$16.52M |
| **EBITDA** | -$30.56M | -$95.88M | -$66.84M | -$55.24M | -$42.61M | -$22.11M | -$16.49M |
| Interest Income | $1.13M | $2.95M | $4.50M | $1.04M | $102K | $82K | $213K |
| Income Before Tax | -$28.91M | -$93.40M | -$62.62M | -$55.27M | -$43.51M | -- | -- |
| Income Tax Expense | $11K | $39K | $59K | $13K | $0 | $0 | $0 |
| **Net Income** | -$28.92M | -$93.44M | -$62.68M | -$55.28M | -$43.51M | -$22.13M | -$16.31M |
| Basic EPS | -$18.62 | -$71.75 | -$63.00 | -$91.50 | -$167.50 | -$129.50 | -$4,111.50 |
| **Diluted EPS** | -$18.62 | -$71.75 | -$63.00 | -$91.50 | -$167.50 | -$129.50 | -$4,111.50 |
| Basic Shares Outstanding | 1.6M | 1.3M | 996.1K | 604.7K | 259.7K | 171.8K | 4.0K |
| Diluted Shares Outstanding | 1.6M | 1.3M | 996.1K | 604.7K | 259.7K | 171.8K | 4.0K |

### Income Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $7.0K | $25K | $183K | $183K | $209K | $195K | $598K | $532K |
| Research & Development | $4.38M | $4.05M | $5.11M | $4.88M | $6.36M | $5.90M | $13.26M | $18.24M |
| Total Operating Expenses | $7.12M | $6.26M | $9.01M | $9.02M | $11.62M | $12.64M | $49.57M | $24.06M |
| **Operating Income** | -$7.12M | -$6.24M | -$8.83M | -$8.84M | -$11.41M | -$12.44M | -$48.97M | -$23.52M |
| **EBITDA** | -$7.02M | -$6.14M | -$8.63M | -$8.71M | -$11.26M | -$12.40M | -$48.77M | -$23.39M |
| Interest Income | $169K | $256K | $410K | $298K | $435K | $576K | $855K | $1.09M |
| Income Before Tax | -$6.95M | -$5.98M | -$7.43M | -$8.54M | -$10.97M | -$11.87M | -$48.12M | -$22.44M |
| Income Tax Expense | $2.0K | $3.0K | $2.0K | $4.0K | $6.0K | $7.0K | $12K | $14K |
| **Net Income** | -$6.95M | -$5.98M | -$7.44M | -$8.55M | -$10.98M | -$11.87M | -$48.13M | -$22.45M |
| Basic EPS | -- | -$3.38 | -$5.51 | -$6.50 | -- | -$9.07 | -$36.76 | -$17.50 |
| **Diluted EPS** | -- | -$3.38 | -$5.51 | -$6.50 | -- | -$9.07 | -$36.76 | -$17.50 |
| Basic Shares Outstanding | -- | 1.8M | 1.3M | 1.3M | -- | 1.3M | 1.3M | 1.3M |
| Diluted Shares Outstanding | -- | 1.8M | 1.3M | 1.3M | -- | 1.3M | 1.3M | 1.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.89M | $40.58M | $22.35M | $32.55M | $45.75M | $74.59M | $9.81M |
| Short-Term Investments | $0 | $0 | $80.40M | $65.34M | $0 | -- | -- |
| **Cash & Short-Term Investments** | $15.89M | $40.58M | $102.8M | $97.89M | $45.75M | $74.59M | $9.81M |
| **Total Current Assets** | $16.27M | $43.02M | $104.8M | $100.8M | $47.92M | $75.92M | $10.12M |
| Property, Plant & Equipment, Net | $1.05M | $1.40M | $2.04M | $2.24M | $4.50M | $2.17M | $237K |
| Other Non-Current Assets | -- | $0 | $1.11M | $3.28M | $762K | $118K | $1.10M |
| **Total Non-Current Assets** | $19.84M | $23.32M | $37.78M | $9.14M | $6.95M | $4.91M | $4.84M |
| **Total Assets** | $36.11M | $66.35M | $142.6M | $110.0M | $54.87M | $80.83M | $14.96M |
| Accounts Payable | $663K | $1.18M | $3.13M | $2.62M | $3.12M | $922K | $1.07M |
| Deferred Revenue (Current) | -- | $398K | $1.66M | $1.27M | $9.79M | -- | -- |
| Other Current Liabilities | $518K | $475K | $1.23M | $659K | $633K | $149K | $110K |
| **Total Current Liabilities** | $9.52M | $12.63M | $19.60M | $14.47M | $18.25M | $4.88M | $5.21M |
| Deferred Revenue (Non-Current) | $11.86M | $11.86M | $12.14M | $14.08M | $1.93M | -- | -- |
| **Total Non-Current Liabilities** | $37.30M | $42.12M | $33.58M | $14.74M | $2.31M | $1.45M | $2.43M |
| **Total Liabilities** | $46.83M | $54.75M | $53.18M | $29.21M | $20.55M | $6.34M | $7.63M |
| **Total Debt (incl. Leases)** | $30.26M | $34.38M | $26.88M | $2.22M | $1.45M | $2.44M | $3.33M |
| Common Stock | $2.0K | $1.0K | $57K | $32K | $13K | $13K | -- |
| Retained Earnings | -$433.7M | -$404.8M | -$311.4M | -$248.7M | -$193.4M | -$149.9M | -$127.8M |
| Accumulated Other Comp. Income | -- | $0 | $33K | $10K | -- | -- | -- |
| **Total Stockholders' Equity** | -$10.72M | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | -$123.3M |
| Total Equity | -$10.72M | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | -$123.3M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.89M | $22.05M | $29.78M | $31.73M | $40.58M | $23.80M | $31.91M | $15.80M |
| Short-Term Investments | $0 | -- | -- | -- | $0 | $27.83M | $35.59M | $71.32M |
| **Cash & Short-Term Investments** | $15.89M | $22.05M | $29.78M | $31.73M | $40.58M | $51.63M | $67.50M | $87.12M |
| **Total Current Assets** | $16.27M | $23.02M | $31.06M | $33.91M | $43.02M | $54.44M | $69.44M | $89.44M |
| Property, Plant & Equipment, Net | $1.05M | $1.12M | $1.16M | $1.28M | $1.40M | $1.61M | $1.67M | $3.78M |
| Other Non-Current Assets | -- | -- | -- | -- | $0 | -- | -- | $683K |
| **Total Non-Current Assets** | $19.84M | $20.69M | $21.51M | $22.41M | $23.32M | $24.31M | $25.15M | $52.08M |
| **Total Assets** | $36.11M | $43.71M | $52.57M | $56.32M | $66.35M | $78.76M | $94.58M | $141.5M |
| Accounts Payable | $663K | $627K | $680K | $725K | $1.18M | $2.29M | $4.97M | $2.84M |
| Deferred Revenue (Current) | -- | $7.0K | $32K | $216K | $398K | $607K | $814K | $1.32M |
| Other Current Liabilities | $518K | -- | -- | -- | $475K | -- | -- | -- |
| **Total Current Liabilities** | $9.52M | $9.48M | $11.16M | $11.47M | $12.63M | $14.95M | $19.28M | $18.72M |
| Deferred Revenue (Non-Current) | $11.86M | $11.86M | $11.86M | $11.86M | $11.86M | $11.86M | $11.85M | $11.94M |
| **Total Non-Current Liabilities** | $37.30M | $38.56M | $39.79M | $40.97M | $42.12M | $43.18M | $44.33M | $45.30M |
| **Total Liabilities** | $46.83M | $48.04M | $50.95M | $52.44M | $54.75M | $58.14M | $63.60M | $64.02M |
| **Total Debt (incl. Leases)** | $30.26M | $31.38M | $32.48M | $33.36M | $34.38M | $35.32M | $36.75M | $37.86M |
| Common Stock | $2.0K | $2.0K | $2.0K | $66K | $1.0K | $65K | $65K | $61K |
| Retained Earnings | -$433.7M | -$426.8M | -$420.8M | -$413.3M | -$404.8M | -$393.8M | -$381.9M | -$333.8M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | $20K | -$4.0K | $25K |
| **Total Stockholders' Equity** | -$10.72M | -$4.33M | $1.62M | $3.87M | $11.59M | $20.62M | $30.98M | $77.50M |
| Total Equity | -$10.72M | -$4.33M | $1.62M | $3.87M | $11.59M | $20.62M | $30.98M | $77.50M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.92M | -$93.44M | -$62.68M | -$55.28M | -$43.51M | -$22.13M | -$16.31M |
| Depreciation & Amortization | $459K | $471K | $278K | $1.07M | $1.00M | $95K | $27K |
| Stock-Based Compensation | $2.33M | $6.72M | $5.89M | $5.45M | $2.77M | $1.81M | $244K |
| Change in Payables | -$516K | -$1.89M | $450K | -$2.41M | $2.35M | $345K | -$205K |
| **Operating Cash Flow** | -$28.86M | -$70.01M | -$63.30M | -$43.38M | -$25.82M | -$21.14M | -$13.75M |
| Capital Expenditure | -$116K | -$2.34M | -$1.05M | -$164K | -$3.38M | -$1.77M | -$211K |
| **Free Cash Flow** | -$28.98M | -$72.35M | -$64.35M | -$43.55M | -$29.20M | -$22.92M | -$13.96M |
| Purchases of Investments | -- | -$47.95M | -$122.4M | -$64.84M | -- | -- | -- |
| **Investing Cash Flow** | -$98K | $80.31M | -$12.58M | -$65.01M | -$3.38M | -$1.77M | -$211K |
| **Financing Cash Flow** | $4.27M | $8.53M | $65.69M | $96.26M | $359K | $87.70M | -$115K |
| **Net Change in Cash** | -$24.68M | $18.82M | -$10.20M | -$12.13M | -$28.85M | $64.78M | -$14.08M |

### Cash Flow Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.95M | -$5.98M | -$7.44M | -$8.55M | -$10.98M | -$11.87M | -$48.13M | -$22.45M |
| Depreciation & Amortization | $100K | $100K | $200K | $128K | $151K | $39K | $200K | $136K |
| Stock-Based Compensation | $562K | $34K | $914K | $825K | $1.94M | $1.49M | $1.12M | $2.16M |
| Change in Payables | $103K | -$120K | -$45K | -$454K | -$1.11M | -$2.59M | $2.38M | -$560K |
| **Operating Cash Flow** | -$6.07M | -$7.36M | -$6.59M | -$8.84M | -$11.35M | -$16.22M | -$19.98M | -$22.45M |
| Capital Expenditure | -- | -- | -- | -- | $58K | -$51K | -$196K | -$2.15M |
| **Free Cash Flow** | -- | -- | -- | -- | -$11.29M | -$16.27M | -$20.18M | -$24.60M |
| Purchases of Investments | -- | -- | -- | -- | $0 | -$12.81M | -$14.62M | -$20.52M |
| **Investing Cash Flow** | -- | -- | -- | -- | $28.13M | $8.14M | $36.18M | $7.86M |
| **Financing Cash Flow** | -- | -- | -- | -- | -$1.0K | -$23K | -$89K | $8.64M |
| **Net Change in Cash** | -$6.16M | -$7.73M | -$1.95M | -$8.84M | $16.78M | -$8.11M | $16.11M | -$5.95M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -7794.5% | -6280.8% | -4308.1% | -4131.0% | -15303.5% | -- | -- |
| **Net Profit Margin** | -7266.1% | -6090.9% | -4023.1% | -4055.6% | -15267.7% | -- | -- |
| Return on Equity (ROE) | -- | -805.9% | -70.1% | -68.5% | -126.8% | -29.7% | -- |
| Return on Assets (ROA) | -80.1% | -140.8% | -44.0% | -50.3% | -79.3% | -27.4% | -109.0% |
| Current Ratio | 1.71x | 3.41x | 5.35x | 6.97x | 2.63x | 15.54x | 1.94x |
| Quick Ratio | 1.67x | 3.21x | 5.24x | 6.77x | 2.51x | 15.27x | 1.88x |
| Debt to Equity | -- | 2.97x | 0.30x | 0.03x | 0.04x | 0.03x | -- |
| **Revenue Growth (YoY)** | -74.1% | -1.5% | +14.3% | +378.2% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -7794.5% | -5885.3% | -5391.8% | -6891.6% | -6280.8% | -6894.4% | -5813.3% | -4364.9% |
| **Net Profit Margin** | -7266.1% | -5491.2% | -5043.6% | -6711.4% | -6090.9% | -6635.8% | -5570.9% | -4099.8% |
| Return on Equity (ROE) | -- | -- | -2394.3% | -2054.0% | -805.9% | -473.4% | -327.3% | -88.9% |
| Return on Assets (ROA) | -80.1% | -75.4% | -73.9% | -141.2% | -140.8% | -123.9% | -107.2% | -48.7% |
| Current Ratio | 1.71x | 2.43x | 2.78x | 2.96x | 3.41x | 3.64x | 3.60x | 4.78x |
| Quick Ratio | 1.67x | 2.33x | 2.67x | 2.77x | 3.21x | 3.45x | 3.50x | 4.65x |
| Debt to Equity | -- | -- | 20.02x | 8.61x | 2.97x | 1.71x | 1.19x | 0.49x |
| **Revenue Growth (YoY)** | -96.7% | -87.2% | -69.4% | -65.6% | +43.2% | -64.2% | +30.6% | +29.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
